Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 67.60
+1.20 (1.81%)
At close: Sep 3, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 7.26 billion as of September 4, 2026. Its market cap has increased by 6.12% in one year.
Market Cap
7.26B
Enterprise Value
10.91B
Revenue
10.57B
Ranking
n/a
PE Ratio
12.06
Stock Price
67.60
ChartMarket Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 7.26B, an increase of 156.06%. That is a compound annual growth rate of 27.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 7.26B | 30.25% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 24.62B |
| The ACME Laboratories | 16.74B |
| Asiatic Laboratories | 13.34B |
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Orion Pharma | 6.18B |
| Techno Drugs | 5.87B |
| Indo-Bangla Pharmaceuticals | 2.03B |
| Silco Pharmaceuticals | 1.85B |